178 related articles for article (PubMed ID: 28207933)
1. Chorionic villus sampling in the cell-free DNA aneuploidy screening era: careful selection criteria can maximise the clinical utility of screening and invasive testing.
Kane SC; Reidy KL; Norris F; Nisbet DL; Kornman LH; Palma-Dias R
Prenat Diagn; 2017 Apr; 37(4):399-408. PubMed ID: 28207933
[TBL] [Abstract][Full Text] [Related]
2. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
[TBL] [Abstract][Full Text] [Related]
3. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
4. UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptake.
Gil MM; Giunta G; Macalli EA; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):67-73. PubMed ID: 25302655
[TBL] [Abstract][Full Text] [Related]
5. Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015.
Johnson K; Kelley J; Saxton V; Walker SP; Hui L
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):152-156. PubMed ID: 28295165
[TBL] [Abstract][Full Text] [Related]
6. National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell-free DNA aneuploidy screening.
Robson SJ; Hui L
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):507-10. PubMed ID: 26259499
[TBL] [Abstract][Full Text] [Related]
7. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
Lostchuck E; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
9. Chorionic villus sampling for abnormal screening compared to historical indications: prevalence of abnormal karyotypes.
Marshall NE; Fraley G; Feist C; Burns MJ; Pereira L
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1463-6. PubMed ID: 22098166
[TBL] [Abstract][Full Text] [Related]
10. Uptake of noninvasive prenatal testing at a large academic referral center.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
[TBL] [Abstract][Full Text] [Related]
11. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.
Norton ME; Baer RJ; Wapner RJ; Kuppermann M; Jelliffe-Pawlowski LL; Currier RJ
Am J Obstet Gynecol; 2016 Jun; 214(6):727.e1-6. PubMed ID: 26709085
[TBL] [Abstract][Full Text] [Related]
12. Estimation of Detection Rates of Aneuploidy in High-Risk Pregnancy Using an Approach Based on Nuchal Translucency and Non-Invasive Prenatal Testing: A Cohort Study.
Khalil A; Mahmoodian N; Kulkarni A; Homfray T; Papageorghiou A; Bhide A; Thilaganathan B
Fetal Diagn Ther; 2015; 38(4):254-61. PubMed ID: 25925597
[TBL] [Abstract][Full Text] [Related]
13. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
[TBL] [Abstract][Full Text] [Related]
14. Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening.
Scarff KL; Flowers N; Love CJ; Archibald AD; Hunt CE; Giouzeppos O; Elliott J; Delatycki MB; Pertile MD
Prenat Diagn; 2023 Feb; 43(2):213-225. PubMed ID: 36617980
[TBL] [Abstract][Full Text] [Related]
15. Prenatal invasive testing: a 13-year single institution experience.
Comas C; Echevarria M; Rodríguez I; Serra B; Cirigliano V
J Matern Fetal Neonatal Med; 2014 Aug; 27(12):1209-12. PubMed ID: 24131234
[TBL] [Abstract][Full Text] [Related]
16. Chorionic Villus Sampling, Early Amniocentesis, and Termination of Pregnancy Without Diagnostic Testing: Comparison of Fetal Risk Following Positive Non-invasive Prenatal Testing.
Zelig CM; Knutzen DM; Ennen CS; Dolinsky BM; Napolitano PG
J Obstet Gynaecol Can; 2016 May; 38(5):441-445.e2. PubMed ID: 27261219
[TBL] [Abstract][Full Text] [Related]
17. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?
Huang LY; Pan M; Han J; Zhen L; Yang X; Li DZ
J Obstet Gynaecol; 2018 May; 38(4):498-501. PubMed ID: 29433355
[TBL] [Abstract][Full Text] [Related]
18. Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies.
Grati FR; Bajaj K; Zanatta V; Malvestiti F; Malvestiti B; Marcato L; Grimi B; Maggi F; Simoni G; Gross SJ; Ferreira J
Prenat Diagn; 2017 Oct; 37(10):1017-1027. PubMed ID: 28801976
[TBL] [Abstract][Full Text] [Related]
19. Incidence of sex chromosome aneuploidy in a prenatal population: 27-year longitudinal study in Northern Italy.
Samango-Sprouse CA; Grati FR; Brooks M; Hamzik MP; Khaksari K; Gropman A; Taylor A; Malvestiti F; Grimi B; Liuti R; Milani S; Chinetti S; Trotta A; Agrati C; Repetti E; Martin KA
Ultrasound Obstet Gynecol; 2023 Aug; 62(2):266-272. PubMed ID: 36929222
[TBL] [Abstract][Full Text] [Related]
20. [Implementation of arrays in first trimester prenatal diagnosis].
Trková M; Putzová M; Bečvářová V; Horáček J; Soldátová I; Krautová L; Sekowská M; Hodačová J; Hnyková L; Hlavová E; Smetanová D; Stejskal D
Ceska Gynekol; 2015 Jun; 80(3):176-80. PubMed ID: 26087211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
